StockDuty ← Dashboard Aug 21, 2026 12:04 AM ET
CatalystFDA/Bio

ARGENX SE (ARGX) DISCUSSES POSITIVE PHASE 3 ALKIVIA TRIAL RESULTS FOR VYVGART HYTRULO IN AUTOIMMUNE MYOSITIS - SLIDESHOW - SEEKINGALPHA

Phase 3 ALKIVIA trial positive results for Vyvgart Hytrolo in autoimmune myositis.

What changed
Why it matters
Phase 3 ALKIVIA trial positive results for Vyvgart Hytrolo in autoimmune myositis.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →